Femasys Inc
Femasys Inc., a biomedical company, develops therapeutic and diagnostic solutions to address unmet women healthcare needs in the United States and internationally. The company offers FemaSeed, an intratubal insemination solution; FemVue, a companion diagnostic for fallopian tube assessment through ultrasound; FemCerv, an endocervical tissue sampler for cervical cancer diagnosis; FemCath, a cornua… Read more
Femasys Inc (FEMY) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: -1.182x
Based on the latest financial reports, Femasys Inc (FEMY) has a cash flow conversion efficiency ratio of -1.182x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-5.39 Million) by net assets ($4.56 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Femasys Inc - Cash Flow Conversion Efficiency Trend (2019–2024)
This chart illustrates how Femasys Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Femasys Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Femasys Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Katapult Holdings Inc
NASDAQ:KPLT
|
-0.068x |
|
SRM Entertainment, Inc. Common Stock
NASDAQ:SRM
|
0.000x |
|
Kapsch TrafficCom AG
LSE:0GTO
|
0.006x |
|
Bougainville Copper Limited
PINK:BOCOF
|
-0.087x |
|
Hwacheon Mac
KO:000850
|
0.007x |
|
BAJEL PROJECTS LTD
NSE:BAJEL
|
0.089x |
|
Afi Properties Ltd
TA:AFPR
|
0.032x |
|
Skarbiec Holding S.A.
WAR:SKH
|
-1.431x |
Annual Cash Flow Conversion Efficiency for Femasys Inc (2019–2024)
The table below shows the annual cash flow conversion efficiency of Femasys Inc from 2019 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $2.30 Million | $-19.44 Million | -8.438x | -1272.75% |
| 2023-12-31 | $18.35 Million | $-11.28 Million | -0.615x | +12.70% |
| 2022-12-31 | $15.24 Million | $-10.73 Million | -0.704x | -133.77% |
| 2021-12-31 | $26.33 Million | $-7.93 Million | -0.301x | +78.46% |
| 2020-12-31 | $3.53 Million | $-4.93 Million | -1.398x | -676.44% |
| 2019-12-31 | $-45.37 Million | $-11.01 Million | 0.243x | -- |